RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/5728
https://w3id.org/ripe/ripe-kg/retraction-notice/5728
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA02C7C24523188961 |
prov:used |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripekg:evaluation/RIPEA6DBDE4E81DF5F0FA |
prov:used |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prism:doi |
10.1001/jamainternmed.2016.3771 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prism:publicationDate |
2016-09-01 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prism:publicationName |
Archives of Internal Medicine |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
dcterms:publisher |
ripekg:publisher/RIPEP895DD44FBC5E3487JAMA Network |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
dcterms:title |
Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1001%2Farchinte.165.15.1743 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
rdf:type |
owl:Thing |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
owl:sameAs |
https://semopenalex.org/work/W2465889832 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA02C7C24523188961 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA6DBDE4E81DF5F0FA |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA02C7C24523188961 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA6DBDE4E81DF5F0FA |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripe:concerns |
ripekg:author/RIPEAU3FF7BB838D14EAB5Tomohiro Kanoko |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripe:concerns |
ripekg:work/10.1001%2Farchinte.165.15.1743 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripe:rationale |
Concerns/Issues About Authorship/Affiliation;Concerns/Issues About Data;Misconduct by Author |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
ripe:retractionWatchRecordId |
5728 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-1-3 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-inspectai-1-3 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-human-1-1 |
ripekg:retraction-notice/5728Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-inspectai-1-1 |